Biotech · Private company · La Jolla, CA, US
Phusis Therapeutics, Inc.
Track this companyFree. Adds Phusis Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment of multi-field actinitc keratosesFiscal year 2025 · $2.1MNIH RePORTER 1R44CA306740-01 · fetched Nov 12, 2026